Quality Matters | U.S. Pharmacopeia Blog

// March 16, 2021

Quality Raw Materials & Collaboration Essential to mAb COVID-19 Treatment Access in L...

Access to quality raw materials and increased stakeholder collaboration are needed to help ensure availability of monoclonal antibody (mAb) treatments for COVID-19 in low- and middle-income countries (LMICs).

Fouad Atouf, Ph.D.

Ensuring quality COVID-19 vaccine delivery through the ‘last mile’

Medicines

// January 07, 2021

Ensuring quality COVID-19 vaccine delivery through the ‘last mile’...

The COVID-19 pandemic has presented unprecedented challenges around the world, including to national public health systems and the international biopharmaceutical industry.

Jaap Venema

Medicines

// November 02, 2020

Ignore the politics. Trust the science.

Recent politicization of the COVID-19 vaccine development and approval process has led to a concerning loss of confidence in vital governmental institutions. Each day that goes by, the picture seems to grow darker. Politicians criticize scientists without cause.

Anthony Lakavage, J.D.

Medicines

// March 16, 2021

Quality Raw Materials & Collaboration Essential to mAb COVID-19 Treatment Access in L...

Fouad Atouf, Ph.D.

Medicines

// February 02, 2021

Are my medicines at risk of a shortage?

Consumers in the United States often have access to a lot of information about the products they use and consume. Many products include information about the country of origin.

Vimala Raghavendran Zhengrong Ma

Glycosylation in monoclonal antibody treatments for COVID-19

Medicines

// September 17, 2020

Glycosylation in monoclonal antibody treatments for COVID-19...

COVID-19 is transforming our ways of thinking about the development, manufacture and delivery of critical medicines to patients around the world.

Annu Uppal, Ph.D. Jingzhong (Tim) Guo, Ph.D.

Featured Videos

View All Videos

Quality Medicines for Malaria

Global Health

// May 24, 2018

Quality Medicines for Malaria

Marie Lamy with Asia Pacific Leaders Malaria Alliance discusses how one country is tackling drug resistance in order to eradicate Malaria.

Rob Anderson

Poor quality medicines and drug resistance

Global Health

// May 24, 2018

Poor quality medicines and drug resistance

Harvard professor and physician Ashish Jha describes how poor quality medicines create the perfect opportunity for superbugs.

Rob Anderson

Quality medicines and sub-Saharan Africa

Global Health

// May 24, 2018

Quality medicines and sub-Saharan Africa

Global health advocate Mirfin Moundu talks about the dangers of poor quality medicines and how they are a threat to many Africans in treating infectious diseases and non-communicable diseases.

Rob Anderson

Discover More:

I am interested in:

and:

Medicines

// April 01, 2021

COVID-19 Vaccine Handling: Maximizing Doses & Public Confidence...

USP’s COVID-19 Vaccine Handling Toolkit is designed to help address the challenges nurses and other healthcare providers face every day in preparing, distributing and administering essential vaccines.

Nurisha Wade

Medicines

// March 12, 2021

Nitrosamine impurities in medicines: what’s the risk?...

In simple terms, risk is the possibility of something bad happening. It’s the uncertainty around the consequences of an activity with respect to something that we value.

Edmond Biba, Ph.D. Donald Min, PhD

Medicines

// March 12, 2021

Nitrosamine Impurities in Medicines: Preventing history from repeating itself...

The presence of objectionable levels of chemical impurities in pharmaceuticals can have serious public health impacts.

Edwin Gump, PhD

From the Field: USP Vaccine Handling Toolkit Is Shot In The Arm For Administration Effort

Medicines

// March 11, 2021

From the Field: USP Vaccine Handling Toolkit Is Shot In The Arm For Administration E...

USP’s recently released COVID-19 Vaccine Handling Toolkit is helping to fill critical operational efficiency gaps that practice settings have identified in vaccine administration.

Nurisha Wade

Medicines

// November 13, 2020

Breeding a superbug: how poor-quality medicines fuel AMR...

Another public health crisis looms in the wake of the COVID-19 pandemic.

The Role of Standards in Supporting Quality Vaccines Manufacturing and Distribution

Medicines

// July 30, 2020

The Role of Standards in Supporting Quality Vaccines Manufacturing and Distribution...

The scale and speed of the global vaccine research and development effort in response to COVID-19 is unprecedented.

John Kokai-Kun, Ph.D.

It’s #NationalMinorityHealthMonth. COVID-19’s impact on racial and ethnic minorities highlights the need for health… https://t.co/JE5OzrjvgW

— (USPharmacopeia)

Are you a scientist interested in the effort to ensure access to quality medicines and vaccines? Visit Our Science… https://t.co/ODMFKVam99

— (USPharmacopeia)

Informative story by @DerekStaahl. Proud that USP's #COVID19 Vaccine Handling Toolkit is helping vaccinators maximi… https://t.co/MnKlRamNci

— (USPharmacopeia)

Medicines help youth with HIV/AIDS live longer and healthier, and reduce the potential of transmitting #HIV/AIDS to… https://t.co/q1hXfdxEiv

— (USPharmacopeia)

USP’s factsheet on #COVID19 #Vaccine Beyond Use Dates has been updated to reflect the latest Moderna EUA informatio… https://t.co/dc8xnUeNe3

— (USPharmacopeia)

Substandard and falsified #medicines may foster #AMR and negative health outcomes. New research from USP's Quality… https://t.co/XydNtnO0o0

— (USPharmacopeia)

The PQM+ team is pleased to work with National Quality Control Lab staff in countries like #Ethiopia. NQCLs detect… https://t.co/YDu9msLDu7

— (USPharmacopeia)

USP’s #COVID19 #Vaccine Handling Toolkit helps address challenges nurses and other healthcare providers face in pre… https://t.co/ARoVnDaiXz

— (USPharmacopeia)

Watch how the USP COVID-19 Vaccine Handling Toolkit can help healthcare practitioners consistently maximize doses p… https://t.co/23GZPYYyKl

— (USPharmacopeia)

Our #COVID19 Vaccine Handling Toolkit update includes strategies on preparation, storage & transportation for all 3… https://t.co/EoKqxF4sRl

— (USPharmacopeia)

Join us, @IPAOfficialPage, @AccessibleMeds & IGBA April 7-8 for a virtual workshop on Nitrosamines in… https://t.co/4A8GoBQcTI

— (USPharmacopeia)

#Pharmacists continue to play a critical roll in the fight against #COVID19. We applaud #TeamVaccines' efforts to i… https://t.co/t4R0vezNZq

— (USPharmacopeia)

Uninterrupted access to quality-assured medicines is essential to #EndTB.@USAID’s PQM+ team works closely w/… https://t.co/0ZW6xCPcpG

— (USPharmacopeia)

Join @NABP Thurs, March 25 1-2 p.m. CDT for the free webinar: USP COVID-19 Vaccine Handling Toolkit: Operational Co… https://t.co/fkmsj5MGFo

— (USPharmacopeia)

USP’s guide on transporting #COVID19 #vaccines provides strategies for maintaining recommended temperatures during… https://t.co/sHvLjUx5SF

— (USPharmacopeia)

Congratulations to USP Board Chair @SusanWinckler on receiving the 2021 Jacob W. Miller Award from @APhAFoundation.… https://t.co/iaZOMHr0TR

— (USPharmacopeia)

Thanks to all who tuned in to last week's webinar! The discussion was full of critical insights on the best ways to… https://t.co/DXBe1paztd

— (USPharmacopeia)

Access to quality raw materials and increased stakeholder collaboration are needed to ensure availability of… https://t.co/OE00dGZdWf

— (USPharmacopeia)

It’s #WomensHistoryMonth. We’re celebrating & highlighting some USP women trailblazers like Dr. Clara Marshall, the… https://t.co/gf3MTY7IHE

— (USPharmacopeia)

We salute Ambar Keluskar and the many other pharmacists around the country working tirelessly to administer… https://t.co/mDmVskon1E

— (USPharmacopeia)

To support #Bangladesh’s #COVID19 response, @USAIDGH’s PQM+ program worked w/ the Directorate General of Drug Admin… https://t.co/Shak5BzHiN

— (USPharmacopeia)

On the role of pharmacists in #COVID19 vaccination, @DrCDuggan of @FIP_org noted that "In 34 countries, representin… https://t.co/PFHPrrkXvj

— (USPharmacopeia)

Dr. Jameel (@AshokaU) cited India’s polio vaccination campaign as an example to learn from as we combat #COVID19. P… https://t.co/ki6rfloCbJ

— (USPharmacopeia)

.@DrBGellin of @sabinvaccine on helping communities #TrustTheVaccine: "The key is transparency so that people can s… https://t.co/gb9ZlWpet4

— (USPharmacopeia)

.@DrBGellin (@sabinvaccine) explained how R&D and authorization of #COVID19 vaccines have been accelerated w/o taki… https://t.co/otmBgOgiO0

— (USPharmacopeia)